Generics 50

Originals

Biosimilars

Medical devices

Nutraceuticals

Filters

Erythromycin stearate manufacturers

50 products found

Filters

50 products found

erythromycin stearate

Tablets 250 mg, 500 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Unavailable markets
United States
Manufacturer #12170
This company has been involved in the development, production, and regulatory support of generic pharmaceuticals for over 20+ years and has offices at various locations. They have more than 20+ generic medications registered across Europe. The items are sold on more than five continents.

Manufacturer usually replies in 30 days

erythromycin stearate

Tablets 250mg, 500mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #19154
This company, established over five decades ago in the South Asian region, is a leading pharmaceutical manufacturer with a focus on quality and innovation. It holds both WHO-GMP and ISO 9001:2000 certifications, demonstrating its commitment to international standards. The company's product portfolio encompasses a wide range of Rx and OTC drugs, catering to both human and veterinary needs. It also manufactures medical devices and food supplements, and distributes its products under its own brand and in partnership with other renowned domestic and multinational companies. Key therapy areas include but are not limited to, cardiovascular, pain management, and anti-infective treatments. The company's production lines utilize advanced technology and adhere to stringent quality control measures. It exports its products to key regions like Southeast Asia, the Middle East, and Africa, showcasing its international reach.

erythromycin stearate

Tablets 500mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #15225
This company focuses on manufacturing and developing affordable, high-quality generic medications, with a global presence spanning five continents. They prioritize accessibility and affordability, addressing diverse medical needs while adhering to strict international quality standards. Their production lines include prescription and over-the-counter medications, with a focus on injectables, solids, and oral dosage forms. They hold multiple international regulatory approvals, including EU and US GMP, and have a proven track record of delivering complex generic drugs. Key therapy areas include oncology, cardiology, and other therapeutic areas, although the specific areas are not explicitly mentioned on the company's website. The company boasts a strong manufacturing network with multiple facilities and a dedicated workforce exceeding 1,000 employees. Their commitment to continuous innovation has ensured their success in the market for over two decades.

Want to see all 50 products?

Subscribe today to benefit from:

  • Streamlined product sourcing - the leading CTD dossiers database focused on finished dosage formulations

  • Direct negotiations - connect and negotiate directly with manufacturers without any brokerage fee

  • Increased profitability - secure the best commercial terms for your business by comparing offers from several manufacturers

Request Subscription

ERYTHROMYCIN STEARATE

Erythromycin Stearate is an antibiotic. It treats and prevents a wide variety of bacterial infections. Erythromycin Stearate inhibits the growth of drug-resistant bacteria, maintains the effectiveness of Erythrocin Stearate Film-coated tablets and other antibacterial drugs. It should be used to treat or prevent infections that are proven strong susceptibility to this medicine. It is indicated in the treatment of mild to moderate degree Upper and lower respiratory tract infections caused by Streptococcus pyogenes or Streptococcus pneumonia or Haemophilus influenza. It also used to treat Listeriosis caused by Listeria monocytogenes, Respiratory tract infections caused by Mycoplasma pneumonia, mild to moderately severe Skin and skin structure infections caused by Streptococcus pyogenes or Staphylococcus aureus, whooping cough caused by Bordetella pertussis, Diphtheria, Erythrasma, Intestinal amebiasis, Acute Pelvic Inflammatory Disease. Erythromycin Stearate is sold as Erythrocin Stearate amongst others. Abbott Laboratories first filed for a patent in the 70s and was given the go-ahead in 1981. Since then the original patent has expired.

DOSAGE AND ADMINISTRATION

Erythromycin Stearate is sold as film-coated tablets. However, the efficacy is best, when the optimal serum levels of erythromycin are reached it is taken in the fasting state or immediately before meals. the initial adult dose is usually 250 mg, taken every 6 hours or 500 mg, taken every 12 hours. Dosage can be increased in the intervals of 4g. In treating children, the Age, weight, and severity of the infection determine the dosage. They are normally given 30 to 50 mg per kilo per day, in equally divided doses. For curing streptococcal infections of the upper respiratory tract the dosage is given for at least ten days. in treating Conjunctivitis of the Newborn Caused by Chlamydia trachomatis, the oral suspension of 50mg per kilo per day, in 4 divided doses for at least 2 weeks. In the treatment of Pneumonia of Infancy Caused by Chlamydia trachomatis, the dose is suspension taken 50 per kilo per day, in four divided doses for at least 3 weeks. For treating Urogenital Infections During Pregnancy Due to Chlamydia Trachomatis, a dose of 500 mg is taken orally every 8 hours on an empty stomach for at least 7 days.

The cost of ERYTHROMYCIN STEARATE

In the USA, the consumers have around $352 for a supply of 30 oral tablets of 250 mg. As with most critical medicines, this medicine made in developing countries by generic drug makers has reduced the end cost significantly. In India, consumers can buy 10 tablets for as low as USD 1.1.

How does Erythromycin Stearate Work?

Erythromycin binding 50S ribosomal subunits of susceptible organisms thus inhibiting protein synthesis. It creates resistance by modifying the 23S rRNA in the 50S ribosomal subunit. It causes insensitivity while efflux can is significant. Overall resulting in the prevention of bacterial protein synthesis. It may also have bacteriostatic or bactericidal actions in different concentrations at the site of infection and the susceptibility of the infecting organism.

Finding Erythromycin Stearate Manufacturers and Suppliers

The best way to find and gain access to Erythromycin Stearate manufacturers and Erythromycin Stearate suppliers is to make through Pipelinepharma's global B2B online marketplace for medicines and other pharmaceuticals. Normally, finding trusted manufacturers and supplies of specific drugs like Erythromycin Stearate can be a time-consuming challenge, but with Pipelinepharma's simple search engine and network of proven partners, the whole process becomes a lot easier. All you need to do to get started is to make use of our integrated search engine and start looking for suppliers or manufacturers of Erythromycin Stearate to work with. You can fine-tune your search results using various filters too, letting you search for Erythromycin Stearate from specific countries.

Interested in Subscription?

Please fill out form and send us your specific requirements, and we will get back to you as soon as possible